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I. Introduction 
Cell-tree .,';ystems from animal cells in which added 
viral messenger RN,*t's (mRNA's)are translated have 
proved useful in studies on eukaryotic protein synthe- 
sis and its control. Of the v/ruses which contain their 
own transcrip~ases for the synti~e:ds of  viral mRNA, 
however, o:dy with reovirus has it been possible to 
synthesise in vitro sufficient intact mRNA for its 
translation to be stt~died in this way [1 -3] .  Vaccinia 
is a large DNA virus which contains an RNA polymer- 
ase activity associated with the virus cores [4]. The 
core polymerase: prepared in vitro from purified virus, 
~-itl effect the synthesis of  RNA having properties 
similar to the viral mRNA present at early times in 
vaccinia-infected cells [4]. This RNA is a mixture of  
species, the sizes of  which are consistent with their 
coding predominantly 'or individual viral proteins 
rather than for very. large precursor molecules as is the 
case with the picornavirus RNA's [5,61. Furthermore 
these RNA species unlike the reovirus mRNA's have 
poty A at their 3'-ends [7]. Ttms these presumptive 
vaccinia mRNA's appear to resemble animal cell mes- 
sengers more than do either of  the other viral mRNA 
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species most readily available for study - those of 
reo- and picornaviruses. As yet, however, no direct 
demonstration f messenger funetion has been re- 
ported for *.his vaccinia RNA. Ht:re we describe its 
translation in two mouse cell-free systems. 
2. Materials and methods 
Vaccinia virus (strain WR) was grown and purified 
essentially according to Joklik [8] as previously de- 
scribed [91- "file method of  Kates and Beeson was 
used in the preparation of  the virus cores [4]. The 
reaction mLxture for RNA synthesir, contained: 
2 X 10 I1 cores; 10/amoles ATP; 5 vmoles each of  
CTP, GTP and UTP; I 0/.tCi [3H I UTP (40 Ci/mmole); 
20 ~umoles MgCI 2; 40 btmoles 2-mercaptoethanol; 
I00 vmoles phosphoenolpytuvate; 100 gg pyruvate 
kinase; 250 ~g Macaloid [lOI ; 200tamoles Tris-HCt, 
pH 8.5; in a total volume of  4.0 ml. Incorporation of 
radioactivity from [3H I UTP into an acid-insolub~.c, 
alkali and RNAase-labile product was completely de- 
pendent upon the presence of  ATP, GTP and CTP. 
The mixture was incubated at 33 ° for 3 hr during 
which incorporation was almost linear, then centri- 
fuged at 30,OOOg for 30 rain to remove tile cores ann 
the Macaloid. The supematant was treated with I 0 
mM EDTA and 1% (w/v) sodium dodecyl sulphate 
(SDS) at 37 ° for 5 min and the rnixture was layered 
onto a i 5-30% sucrose (w/v) gradient in ! 0 mM Tris- 
HCI pH 7.0, 100 mM NaCI, 10 mM EDTA, 0.5% SDS 
and centrifuged in the SW 27 rotor at 70,000g for 
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20 hr at •20 °. Fractions were collected and aliquots 
were taken for measurement of acid-insoluble radioac- 
tivity. The fraction s containing the greater part of  the 
RNA were pooled and precipitated by the addition of  
2.5 vol o f  ethanol. After storage overnight at -20" ,  
the RNA was sedimented, washed once with edmnol, 
dried in vacuo and dissolved in sterile water prior to 
storage in small aliquots at -20  °. The/:oncentration 
~as determined  f rom *2re absorbance  nt  260  not  as- 
suming  that an abs0rbance of 1.0 is given by a solu- 
tion of  40pg/ml.  The final yield from such a prepara- 
tion was of the order of 500/aS. 
Ribosome and cell sap components for the Krebs 
cell-free system and the L-cell extracts were prepared 
as previously described [I 1,121. in each case file 
endogenous protein synthetic activity was reduced by 
preincubation of  the post-mitochondrial superuatant 
fraction. The response of  rite Krebs cell-free system 
to added vaccinia RNA was assayed in 30/.tl mixtures 
as for encephalomyocarditis virus (EMC) RNA [ 13] 
except hat incubation was for 60 min at 30: rather 
than 37 ° . For the L-cell-free system each 50/1I reac- 
tion mixture contained the following (final cone.): 
30 mM Tris-HCI, pH 7.6, 7 mM 2-mercaptoethanol. 
3.5 mM Mg acetate, 40 ntM KCI, I mM ATP, 0.1 mM 
GTP, 10 mM creatine Fhosphate, 0.16 mg/ml creatine 
kinase, 5/aCi/ml 14C-amino acid mLxture C > 45 mCi 
per milliatom carbon), 40 mM each of  the amino acids 
not present in the 14C-amino acid mix and 10 to 15 pl 
of L-cell extract [ i 1, i 21 - For the preparation of  ma- 
terial for gel electrophoresis~ the assays were scaled up 
twenty-fold and the 14C-amino acid mixture w~as re- 
placed by [35Slmethionine (20 to 30 Ci/mmole) plus 
the "other nineteen" non-radioactive amino acids. 
50-100/11 aliquots o f  the cell-free system product 
were treated with 2% SDS, 8 M urea and 0.5 M 2-met- 
captoeth,'mol at !00 ° for 2 rain prior to electropttore- 
sis on 10% polyacrylamide gels in tile presence of  SDS 
[14]. The preparation and electrophoresis of
[35 S] rrtethionine-labelled polypeptides from ~accinia- 
• infected cells has already been described [9, ! 5]. Gels 
were sliced longitudinally and subjected to autoradio- 
graphy. 
All radiochemicals were purchased from the 
Radiochemical Centre, Amersham, Bucks, England. 
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Fig. I. Sucro::e gradient sedimentation f 3ll-iabefled vzccinia 
RNA sy~d',esised in v i t ro with the core polymerast-" fronl pu- 
rified virus. Sedimentat ion was from left to right. The bar in- 
dicates the fract ions that were l_'cJoled and precipitated to 
yield the RNA used in the celt-free systems. 
3. Results and di~ussion 
3.1. Char:~cterisation J'zhe vaccinia RAtA altd co~ldi- 
lions fi)r its transla~'ion 
The viral RNA synthesised and released by tli¢ iso- 
lated cores sedinients in a sucrose gradient as :! broad 
peak at about 12 S (fig. !) [41. The sedimentaiion 
behaviour of  this RNA is ve~" similar to that ofe:trly 
vaccinia mRNA seen in infected cells shortly after in- 
fection [4, 9].  Electrophoresis of the RNA in poly- 
actTiamide gels yielded :it least 10 discrete species of  
3 X 104 to 106 in apparent melee'tint weight on the 
basis of  comparison with marker I;'.NA's (fig. 2). 
The conditions for optimal stiimulatiotl o f  umino 
acid incorporation by this RNA i~ the Krebs c~:II-free 
system were very similar to those for EMC RNA 
[ 1 i, 13], maximum incorporation being obtained 
with 4 to 6 mM Mg 2+ in the presence of  50 mM K +. 
Incubation at 30 ° was as good or better than at 37 °. 
Most of  the incorporation occurred during the initial 
20 to 30 thin at either temperature. Typically a ? to 
5-fold stimulatiot: was observed at a saturating RNA 
concentration o f  about 60 tzg/ml. With the L-ceil ex- 
tracts, m.q~imum incorporation of  atnino acids in 
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response to the added vaccinia RNA occurred at 3.5 
mM Mg 2÷, ,tO mM K ÷ and 40 pg/ml o f  RNA and was 
essentially complete after 60 rain at 30 °. 
A 
B m 
C m 
D 
Fig. 2. Vaccinia RNA was t, ahelled with [ t4C]UTP, i~olated 
as described in the text and an amount corresponding to
7,000 cpm was applied to a 2% polyacrylamide g l containing 
0.5% .-,garose and subjected to electrophoresis at 100 V 
(4.5 mA per gel) [or 1.5 hr 123)- A. B,C, and D indicate, 
respectively, t.he positions to which EncephalomyocardP_i5 
virus RNA (37 S) rind 28 S and 18 S ribcsomal RNA and 4 S 
tRNA from mouse Krel;$ as,cites tumour cells included as 
markers migrated. "lttese markers did not affect he distribu- 
tion of the radioactive species of vaccinia RNA. After staining 
-~.-it.l-t mtflaylene blue to .rffxow file u-.dlaboHed sr~3xKet5, Y.hc gels 
were dried and subjected to autoradiography for5 wt~kS. 
3.2. Analysis e l  the polypeptide products ynthesised 
in i°esponse to the vacc,2nia RNA 
In the intact vaccinia virus-infected L-cell a very 
rapid it~hibition of  host protein synthesis occurs im- 
~ediat¢:ty after infection. Thus by 20 to 60 rain post 
infectien the vast majority o f  protein synthesis i vi- 
rus mediated [9, 15717].  This synthesis i thought o 
occur on mRNA's produced by the transcriptase of
the infecting parental virions. [t should be emphasized, 
however, that the synthesis of  the different viral poly- 
peptidea is under very fine control, their relative 
amounts v xy ing with time post infection [9, ! 5, 16 
and fig. 3, ge,'s 4 and 5]. It is not yet known for how 
many o f  these polypeptides fire isolated core polymer- 
a~ from purified virus synthesises mRNA in vitro. An 
estimate for this can be made, however, from the fact 
that about 7% of  the DNA is transcribed [4J to yield 
message'~ theoretically equivalent to approx. 500,000 
molecular weight units of  protein.or 10 to 25 polypep- 
tides of  20,000 to 50,000 in molecular weight. The 
products ynthesised in the cell-flee system and the 
intact celi were compared by electrophoresis on SDS 
polyacrylamide, gels (fig. 3, gels I to 6). It is clear 
that while at least 14 discrete polypeptides are 
formed in the cell-free system in response to the vac- 
cinia mRNA not all of  these correspond to polypep- 
tides present in the intact cell. There is some coinci- 
dence, for example, the pair o f  polypeptides at
approx. 30,000 molecular weight are particularly 
characteristic, but also significant differences (figs. 3 
and 4). Immunological identificatio_-a of the product~ 
has not yet been possible. This may reflect a failure 
in the phosphorylation [ 18] or glycosylation of  pro- 
teins in the cell-free systems, or the fact that the sera 
used contained antibody to " late" rather than "'early" 
viral proteins. A failure in glycosylation or in post- 
translational cleavage [19,201 in the maturation of  
some of  the polypeptide products m the cell-free sys. 
tern could also explain the tact that not all of  these 
products correspond exactly in electroFhoretic mobil- 
ity to those present in the intact infected cell (fig. 3, 
gels l to 6). On the other hand the two mouse cell- 
free systems used here are known to be capable of  
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Volume 30, number  3 FEBS LETTERS March 1973 
. .  . : . .  
) .~- . ;z¢ • 
. . . . . :  . ..' 
60-"-~ 
40~/i 
31--"" ~ 
2 
. -  ..-. 
3 4 
"7.'' 
4 , . . . :  
'~'?-..'.." : 
.-,-'-"..i ~ i:
' - . - . .=7 
".L 
5 6 
- , 4 . ~  
---60 
* -40  
i1~ - -31 -~- 
r~,:.:.: i :. 
~20-°  
!4:..- d 
s 
A B 
Fig. 3. Polyacrylamide gel electrophoresis o f [3SSlmethionine labelled polypept ides synthesJseU m vaccinia-infected ceils and in 
cell-free systems in response to vaccinia RNA.  Infected L-cells pulse labelled from 20-40  rain (gels I and 4) and 60 to 8f_, rain 
(gel 5) post infection. Uninfected cells pulse labelled for 20 rain (gel 6). Krebs celbfree system with (gels 3 and 9) and witlio~tt 
(gels 2 and |0 )  vaccinia RNA. |.-cell extcacts with (gel 8) and without  (gel 7) vacciJ~ia RNA. Gels 1 l.o 6 and 7 to 10 were run on 
separate occasions. The approx, molecular weights (× I 0 -1)  o f  some of  the infected-cell polypeptides are shown. 
the t rans la t ion  o f  added mRNA's  in the  fo rm o f  
mouse globin and EMC RNA's [I 2, 20--221 . Moreover, 
in preliminary experiments, fingerprints o f  tryptic pep- 
tides of  the vaecinia RNA-stimulated products formed 
in both  the  Krebs  and  L ce l l - f ree  sys tems showed def -  
inite similar,:ties with those fiom vaccinia polypep- 
tides formed at 20 to 60 rain but not ! 80 rain post 
infection in the intact cell. They were, o f  courser' 
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Fig. 4. Compaxi~m of  the polypeptides formed in response to 
vaccinia RNA in the Krebs cell-free system with early vaccinia 
polypeptides from infected L-cells. Analysis of  the [3SS] me- 
thionine-labelled polypeptides was by electrophoresis on SDS- 
polyacrylamide gels. The figure presents den~tometer tracings 
of" autoradiograms of  the dried gels ~ith the origins to the 
ri#tt. A) Vaccinia-infected cell polypeptides pulm labelled 20 
to 40 triin po~t infection_ B and C) Polypeptides from cell- 
free ~'stems incubated with (B) and without (C) vaccinia 
RNA.  
clearly different from those of  the products formed 
in response to EMC RNA in these systems. Finally, 
the same polypeptide products appear to be synthe- 
sised in response to  ttle vaccin ia RNA in the two com-  
pletely dist inct cell-tree sys tems f rom L and  Krebs 
cells (fig. 3 gels 7 to  10). It is reasonable to conc lude ,  
therefore,  that  it is the added vaccinia mRNA that  is 
being translated in the two syst_ems, for  it seems high- 
ly unl ikely that  identicai  po lypept ide  products  wou ld  
.be produ, :ed by an artefactual  vaccinia n iRNA-med i -  
sled stimulation of  the translation of  endogenous 
mRNA of-L cells in the one case and Krebs cells in the 
other. Accordingly, while absolute proof  awaits the 
results o f  a more  detai led s tudy ,  the data presertted 
here clear ly indicate flint the vaccin ia core polymerase 
is mak~,ag RNA which is not  on ly  complementary  to  
vacc~= -. DNA [4] but  is also act ive messenger capable  
o f  bei;lg translated Ln appropr ia te  cell-free systems.  
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